Fortress Biotech, Inc. (FBIO)

Oncology Corporate Profile

Stock Performance

3.8000
0.0000

HQ Location

3 Columbus Circle, 15th Floor
New York, NY 10019

Company Description

Fortress Biotech, Inc. is a biopharmaceutical company dedicated to acquiring, developing and commercializing novel pharmaceutical and biotechnology products. Fortress plans to develop and commercialize products that it acquires both directly as well as indirectly by establishing subsidiary companies, also known as Fortress Companies. The Company will leverage its biopharmaceutical business expertise and drug development capabilities to help the Fortress Companies achieve their goals.

Website: http://www.fortressbiotech.com

This company does not have any commercial products
  • Brand
  • Generic
  • Investigational
Brand / Product Class Area of Study Phase Partnership
CD123 CARCAR T-cell therapyAcute Myelogenous Leukemia (AML)IMustang Bio
CNDO-109CAR T-cell therapyAcute Myelogenous Leukemia (AML)IFortress Biotech
IL13Ra2-specific CARCAR T-cell therapyGliomaIMustang Bio
CK-101EGFR inhibitorNon Small Cell Lung Cancer (NSCLC)ICheckpoint Theraputics
CK-102PARP inhibitorVarious cancer typesICheckpoint Theraputics

View additional information on product candidates here »

Source: http://www.fortressbiotech.com

Recent News Headlines

7/20/2017 06:18 pm

7/20/2017 06:18 pm

7/20/2017 06:18 pm

7/20/2017 06:18 pm

7/20/2017 06:18 pm

7/17/2017 06:18 am

7/17/2017 06:18 am

7/17/2017 06:18 am

7/17/2017 06:18 am

7/17/2017 06:18 am

7/3/2017 06:18 am

7/3/2017 06:18 am

7/3/2017 06:18 am

7/3/2017 06:18 am

7/3/2017 06:18 am

6/30/2017 06:18 am

6/30/2017 06:18 am

6/30/2017 06:18 am

6/30/2017 06:18 am

6/30/2017 06:18 am

6/30/2017 12:18 am

6/27/2017 12:18 pm

6/26/2017 06:18 pm

6/26/2017 06:18 am

6/15/2017 06:18 am